These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28222519)

  • 21. Age-dependent effect of APOE and polygenic component on Alzheimer's disease.
    Bellou E; Baker E; Leonenko G; Bracher-Smith M; Daunt P; Menzies G; Williams J; Escott-Price V;
    Neurobiol Aging; 2020 Sep; 93():69-77. PubMed ID: 32464432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the CD2AP locus with cognitive functioning among middle-aged individuals with a family history of Alzheimer's disease.
    Manzali SB; Ravona-Springer R; Alkelai A; Yu E; Gan-Or Z; Ganmore I; Heymann A; Beeri MS; Greenbaum L
    Neurobiol Aging; 2021 May; 101():50-56. PubMed ID: 33578194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.
    Foley SF; Tansey KE; Caseras X; Lancaster T; Bracht T; Parker G; Hall J; Williams J; Linden DE
    Biol Psychiatry; 2017 Jan; 81(2):154-161. PubMed ID: 27157680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition.
    Leonenko G; Shoai M; Bellou E; Sims R; Williams J; Hardy J; Escott-Price V;
    Ann Neurol; 2019 Sep; 86(3):427-435. PubMed ID: 31199530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of polygenic risk scores with Alzheimer's disease and plasma biomarkers among Chinese older adults: A community-based study.
    Hou T; Liu K; Fa W; Liu C; Zhu M; Liang X; Ren Y; Xu S; Wang X; Tang S; Wang Y; Cong L; Tan Q; Du Y; Qiu C
    Alzheimers Dement; 2024 Oct; 20(10):6669-6681. PubMed ID: 39171679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of polygenic risk for Alzheimer's disease on rate of cognitive decline in normal aging.
    Kauppi K; Rönnlund M; Nordin Adolfsson A; Pudas S; Adolfsson R
    Transl Psychiatry; 2020 Jul; 10(1):250. PubMed ID: 32709845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease.
    Coon KD; Myers AJ; Craig DW; Webster JA; Pearson JV; Lince DH; Zismann VL; Beach TG; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Walker DG; Ravid R; Heward CB; Rogers J; Papassotiropoulos A; Reiman EM; Hardy J; Stephan DA
    J Clin Psychiatry; 2007 Apr; 68(4):613-8. PubMed ID: 17474819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common polygenic variation enhances risk prediction for Alzheimer's disease.
    Escott-Price V; Sims R; Bannister C; Harold D; Vronskaya M; Majounie E; Badarinarayan N; ; ; Morgan K; Passmore P; Holmes C; Powell J; Brayne C; Gill M; Mead S; Goate A; Cruchaga C; Lambert JC; van Duijn C; Maier W; Ramirez A; Holmans P; Jones L; Hardy J; Seshadri S; Schellenberg GD; Amouyel P; Williams J
    Brain; 2015 Dec; 138(Pt 12):3673-84. PubMed ID: 26490334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
    Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
    J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying individuals with high risk of Alzheimer's disease using polygenic risk scores.
    Leonenko G; Baker E; Stevenson-Hoare J; Sierksma A; Fiers M; Williams J; de Strooper B; Escott-Price V
    Nat Commun; 2021 Jul; 12(1):4506. PubMed ID: 34301930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.
    Zhang C; Hu R; Zhang G; Zhe Y; Hu B; He J; Wang Z; Qi X
    J Mol Neurosci; 2019 Nov; 69(3):433-443. PubMed ID: 31346968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.
    Andrews SJ; Das D; Anstey KJ; Easteal S
    J Alzheimers Dis; 2017; 57(2):423-436. PubMed ID: 28269768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of whole-person eigen-polygenic risk scores with Alzheimer's disease.
    Kharaghani A; Tio ES; Milic M; Bennett DA; De Jager PL; Schneider JA; Sun L; Felsky D
    Hum Mol Genet; 2024 Jul; 33(15):1315-1327. PubMed ID: 38679805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polygenic hazard scores in preclinical Alzheimer disease.
    Tan CH; Hyman BT; Tan JJX; Hess CP; Dillon WP; Schellenberg GD; Besser LM; Kukull WA; Kauppi K; McEvoy LK; Andreassen OA; Dale AM; Fan CC; Desikan RS
    Ann Neurol; 2017 Sep; 82(3):484-488. PubMed ID: 28940650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease.
    Handy A; Lord J; Green R; Xu J; Aarsland D; Velayudhan L; Hye A; Dobson R; Proitsi P; ;
    J Alzheimers Dis; 2021; 83(4):1825-1839. PubMed ID: 34459398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and genetic analysis of cognitive performance in Major Depressive Disorder in the Generation Scotland: Scottish Family Health Study.
    Meijsen JJ; Campbell A; Hayward C; Porteous DJ; Deary IJ; Marioni RE; Nicodemus KK
    Transl Psychiatry; 2018 Mar; 8(1):63. PubMed ID: 29531327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's disease.
    Broce IJ; Tan CH; Fan CC; Jansen I; Savage JE; Witoelar A; Wen N; Hess CP; Dillon WP; Glastonbury CM; Glymour M; Yokoyama JS; Elahi FM; Rabinovici GD; Miller BL; Mormino EC; Sperling RA; Bennett DA; McEvoy LK; Brewer JB; Feldman HH; Hyman BT; Pericak-Vance M; Haines JL; Farrer LA; Mayeux R; Schellenberg GD; Yaffe K; Sugrue LP; Dale AM; Posthuma D; Andreassen OA; Karch CM; Desikan RS
    Acta Neuropathol; 2019 Feb; 137(2):209-226. PubMed ID: 30413934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polygenic risk of Alzheimer's disease in the Faroe Islands.
    Johansen M; Joensen S; Restorff M; Stórá T; Christy D; Gustavsson EK; Bian J; Guo Y; Farrer MJ; Petersen MS
    Eur J Neurol; 2022 Aug; 29(8):2192-2200. PubMed ID: 35384166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression from amnesic mild cognitive impairment to Alzheimer's disease: ESR1 and ESR2 polymorphisms and APOE gene.
    Elcoroaristizabal Martín X; Fernández Martínez M; Galdos Alcelay L; Molano Salazar A; Bereincua Gandarias R; Inglés Borda S; Gómez Busto F; Uterga Valiente JM; Indakoetxea Juanbeltz B; Gómez Beldarraín MA; de Pancorbo MM
    Dement Geriatr Cogn Disord; 2011; 32(5):332-41. PubMed ID: 22311091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linear Mixed Model Analysis of Polygenic Hazard Score on Verbal Memory Decline in Alzheimer's Disease.
    Wang K; Xu C; Theeke LA; Xiao D; Luo X; Xie C;
    Nurs Res; 2023 Jan-Feb 01; 72(1):66-73. PubMed ID: 36097266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.